Share on StockTwits

A number of stock research firms have changed their ratings and price targets for AstraZeneca plc (LON: AZN) during the last seven days:

  • AstraZeneca plc had its “hold” rating reaffirmed by analysts at Jefferies Group. They now have a GBX 4,790 ($80.60) price target on the stock.
  • AstraZeneca plc had its “hold” rating reaffirmed by analysts at Berenberg Bank. They now have a GBX 3,775 ($63.52) price target on the stock.
  • AstraZeneca plc had its price target raised by analysts at Deutsche Bank from GBX 3,950 ($66.46) to GBX 4,000 ($67.31). They now have a “hold” rating on the stock.
  • AstraZeneca plc had its “sell” rating reaffirmed by analysts at Societe Generale. They now have a GBX 3,740 ($62.93) price target on the stock.
  • AstraZeneca plc had its “equal weight” rating reaffirmed by analysts at Barclays. They now have a GBX 4,100 ($68.99) price target on the stock.
  • AstraZeneca plc had its “reduce” rating reaffirmed by analysts at Swedbank. They now have a GBX 3,721.79 ($62.62) price target on the stock.

AstraZeneca plc (LON:AZN) opened at 4189.00 on Friday. AstraZeneca plc has a 52-week low of GBX 3086.50 and a 52-week high of GBX 5750.00. The stock’s 50-day moving average is GBX 4367.54 and its 200-day moving average is GBX 4188.18. The company’s market cap is £52.907 billion.

AstraZeneca PLC (LON:AZN) is a global biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.